Xtant Medical Holdings Company Profile (NYSEMKT:BONE)

About Xtant Medical Holdings (NYSEMKT:BONE)

Xtant Medical Holdings logoXtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, BacFast HD, OsteoSTX, hMatrix and 3Demin products, as well as other allografts. Its products serve the needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, foot and ankle surgeries. It also processes and distributes sports allografts, milled spinal allografts and allografts for multi-disciplinary applications.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: N/A
  • Symbol: NYSEMKT:BONE
  • CUSIP: N/A
  • Web: investor.bacterin.com/phoeni...
Average Prices:
  • 50 Day Moving Avg: $3.52
  • 200 Day Moving Avg: $3.68
  • 52 Week Range: $2.19 - $4.75
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.61
  • P/E Growth: 0.00
  • Net Margins: -45.28%
  • Return on Assets: -28.38%
  • Average Volume: 12,977 shs.

Frequently Asked Questions for Xtant Medical Holdings (NYSEMKT:BONE)

What is Xtant Medical Holdings' stock symbol?

Xtant Medical Holdings trades on the New York Stock Exchange (NYSE)MKT under the ticker symbol "BONE."

How were Xtant Medical Holdings' earnings last quarter?

Xtant Medical Holdings Inc (NYSEMKT:BONE) released its earnings results on Wednesday, August, 12th. The company reported ($0.41) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.29) by $0.12. View Xtant Medical Holdings' Earnings History.

Who are some of Xtant Medical Holdings' key competitors?

Who are Xtant Medical Holdings' key executives?

Xtant Medical Holdings' management team includes the folowing people:

  • Kent L. Swanson, Independent Chairman of the Board
  • Carl D. O'Connell, President, Chief Executive Officer
  • Darrel Lee Holmes, Chief Operating Officer
  • Gregory Juda Ph.D., Chief Scientific Officer
  • David Louis Kirschman M.D., Director
  • Paul R. Buckman, Independent Director
  • John Deedrick, Independent Director
  • Michael A. Lopach CPA, Independent Director
  • Rudy A. Mazzocchi, Independent Director

How do I buy Xtant Medical Holdings stock?

Shares of Xtant Medical Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Xtant Medical Holdings' stock price today?

One share of Xtant Medical Holdings stock can currently be purchased for approximately $3.25.

MarketBeat Community Rating for Xtant Medical Holdings (NYSEMKT BONE)
Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  42 (Vote Outperform)
Underperform Votes:  22 (Vote Underperform)
Total Votes:  64
MarketBeat's community ratings are surveys of what our community members think about Xtant Medical Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Xtant Medical Holdings (NYSEMKT:BONE) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Xtant Medical Holdings (NYSEMKT:BONE)
No equities research coverage for this company has been tracked by MarketBeat.com


Earnings History for Xtant Medical Holdings (NYSEMKT:BONE)
Earnings by Quarter for Xtant Medical Holdings (NYSEMKT:BONE)
Earnings History by Quarter for Xtant Medical Holdings (NYSEMKT BONE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/12/2015($0.29)($0.41)ViewN/AView Earnings Details
3/17/2015Q414($0.35)($0.46)$8.90 million$9.10 millionViewN/AView Earnings Details
11/5/2014($0.23)($0.19)ViewN/AView Earnings Details
8/12/2014Q214($0.47)($0.35)$8.85 million$5.60 millionViewN/AView Earnings Details
5/6/2014Q114($0.04)($0.08)$9.73 million$8.90 millionViewN/AView Earnings Details
3/19/2014Q413($0.07)($0.08)$8.00 million$8.30 millionViewN/AView Earnings Details
5/9/2013Q1 2013($0.06)($0.04)ViewN/AView Earnings Details
11/7/2012Q312($0.04)($0.06)$9.29 million$8.90 millionViewN/AView Earnings Details
8/9/2012($0.05)$0.02ViewN/AView Earnings Details
5/3/2012($0.04)($0.03)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Xtant Medical Holdings (NYSEMKT:BONE)
Current Year EPS Consensus Estimate: $-1.38 EPS
Next Year EPS Consensus Estimate: $-0.90 EPS


Dividend History for Xtant Medical Holdings (NYSEMKT:BONE)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Xtant Medical Holdings (NYSEMKT:BONE)
Insider Trades by Quarter for Xtant Medical Holdings (NYSEMKT:BONE)
Insider Trades by Quarter for Xtant Medical Holdings (NYSEMKT:BONE)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/4/2015Daniel S GoldbergerCEOBuy81,522$3.68$300,000.96View SEC Filing  
9/4/2015Jon M WickwireDirectorBuy10,869$3.68$39,997.92View SEC Filing  
5/22/2014Daniel S GoldbergerCEOBuy25,000$0.65$16,250.00View SEC Filing  
5/20/2014Gregory Alexander JudaInsiderBuy20,000$0.69$13,800.00View SEC Filing  
5/7/2014Guy S CookMajor ShareholderSell1,365,000$0.66$900,900.00View SEC Filing  
5/6/2014Guy S CookMajor ShareholderSell885,000$0.75$663,750.00View SEC Filing  
5/2/2014Guy S CookMajor ShareholderSell280,000$0.73$204,400.00View SEC Filing  
4/30/2014Guy S CookMajor ShareholderSell85,000$0.70$59,500.00View SEC Filing  
4/25/2014Guy S CookMajor ShareholderSell100,000$0.70$70,000.00View SEC Filing  
4/24/2014Guy S CookMajor ShareholderSell390,000$0.70$273,000.00View SEC Filing  
4/22/2014Guy S CookMajor ShareholderSell410,000$0.71$291,100.00View SEC Filing  
4/17/2014Guy S CookMajor ShareholderSell75,000$0.70$52,500.00View SEC Filing  
4/9/2014Guy S CookMajor ShareholderSell410,000$0.72$295,200.00View SEC Filing  
1/15/2014Guy S CookMajor ShareholderBuy160,000$0.64$102,400.00View SEC Filing  
1/7/2014Guy S CookMajor ShareholderSell273,300$0.53$144,849.00View SEC Filing  
12/26/2013Guy S CookMajor ShareholderSell64,380$0.53$34,121.40View SEC Filing  
12/24/2013Guy S CookMajor ShareholderSell300,000$0.44$132,000.00View SEC Filing  
12/11/2013Guy S CookMajor ShareholderSell160,000$0.42$67,200.00View SEC Filing  
11/19/2013Gregory Alexander JudaInsiderBuy20,000$0.45$9,000.00View SEC Filing  
11/12/2013Daniel S GoldbergerCEOBuy50,000$0.48$24,000.00View SEC Filing  
9/20/2013Guy S CookMajor ShareholderSell30,000$0.60$18,000.00View SEC Filing  
9/13/2013Darrel Lee HolmesCOOSell30,000$0.57$17,100.00View SEC Filing  
8/28/2013Guy S CookMajor ShareholderSell400,000$0.56$224,000.00View SEC Filing  
8/26/2013Daniel S GoldbergerCEOBuy20,000$0.60$12,000.00View SEC Filing  
8/19/2013Daniel S GoldbergerCEOBuy16,194$0.59$9,554.46View SEC Filing  
8/16/2013Daniel S GoldbergerCEOBuy13,806$0.58$8,007.48View SEC Filing  
6/18/2013Guy S CookMajor ShareholderSell372,859$0.52$193,886.68View SEC Filing  
6/13/2013Guy S CookMajor ShareholderSell175,000$0.55$96,250.00View SEC Filing  
6/13/2013Kent L SwansonDirectorBuy100,000$0.55$55,000.00View SEC Filing  
6/12/2013Guy S CookMajor ShareholderSell2,600$0.55$1,430.00View SEC Filing  
6/11/2013Guy S CookMajor ShareholderSell21,000$0.56$11,760.00View SEC Filing  
6/10/2013Guy S CookMajor ShareholderSell13,400$0.56$7,504.00View SEC Filing  
6/7/2013Guy S CookMajor ShareholderSell88,000$0.56$49,280.00View SEC Filing  
9/11/2012Guy S CookCEOBuy5,000$1.71$8,550.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Xtant Medical Holdings (NYSEMKT:BONE)
Latest Headlines for Xtant Medical Holdings (NYSEMKT:BONE)
thestreet.com logoGlobal Soft Tissue Allografts Market: Overview
www.thestreet.com - September 13 at 10:52 PM
reuters.com logoBRIEF-Xtant Medical Holdings says John P. Gandolfo tendered his resignation as CFO
www.reuters.com - August 29 at 10:12 PM
reuters.com logoBRIEF-Xtant Medical Holdings, units enter seventeenth amendment
www.reuters.com - August 17 at 6:02 PM
streetinsider.com logoDouble Diamond Sponsor K2M to Showcase Newest Spinal Solutions, Industry-Leading 3D-Printed Portfolio, & Balance ACS™ Platform at IMAST 2017
www.streetinsider.com - July 11 at 10:42 PM
reuters.com logoBRIEF-Xtant Medical reschedules annual meeting
www.reuters.com - May 26 at 9:26 PM
nasdaq.com logoXtant Medical Announces Rescheduling of Annual Meeting
www.nasdaq.com - May 26 at 9:26 PM
reuters.com logoBRIEF-Xtant Medical enters licensing agreement for Sites Medical's osteosync TI technology
www.reuters.com - May 16 at 4:06 PM
streetinsider.com logoXtant Medical Holdings (XTNT) Announces Licensing Agreement for Sites Medical’s OsteoSync Ti Technology
www.streetinsider.com - May 16 at 4:06 PM
reuters.com logoBRIEF-Xtant Medical Holdings reports Q1 revenue of $22.1 million
www.reuters.com - May 10 at 8:43 AM
reuters.com logoBRIEF-Xtant Medical's unit entered into thirteenth amendment
www.reuters.com - May 4 at 9:09 PM
nasdaq.com logoPerkins Capital Management Inc Buys LeMaitre Vascular, Abbott Laboratories, ANI ...
www.nasdaq.com - April 20 at 10:40 AM
globenewswire.com logoXtant™ Medical Receives Going Concern Opinion
globenewswire.com - April 7 at 8:39 AM
nasdaq.com logoSee footnote about the use of pro forma financial information
www.nasdaq.com - March 10 at 9:55 PM
reuters.com logoBRIEF-Xtant Medical Holdings Inc says Q4 loss per share $0.31
www.reuters.com - March 10 at 9:55 PM
seekingalpha.com logoXtant Medical Holdings, Inc. 2016 Q4 - Results - Earnings Call Slides
seekingalpha.com - March 10 at 9:55 PM
reuters.com logoBRIEF-Xtant Medical Holding-bacterin International AMENDED EXISTING AMENDED AND RESTATED CREDIT AGREEMENT
www.reuters.com - March 3 at 2:14 AM
streetinsider.com logoXtant Medical Holdings (XTNT) Appoints Carl O'Connell as Permanent CEO
www.streetinsider.com - February 22 at 9:06 PM
nasdaq.com logoXtant Medical CEO Dan Goldberger announces resignation
www.nasdaq.com - January 24 at 1:53 AM
reuters.com logoBRIEF-Xtant unit, Bacterin International enter into eighth amendment to credit agreement
www.reuters.com - January 21 at 3:03 AM
nasdaq.com logoXTNT Announces Closing of Registered Direct Offering
www.nasdaq.com - January 19 at 1:28 AM
globenewswire.com logoXTNT Announces Preliminary Fourth Quarter and Full Year 2016 Revenue & Adjusted EBITDA
globenewswire.com - January 12 at 2:27 AM
reuters.com logoBRIEF-Xtant Medical says unit entered seventh amendment to amended, restated credit agreement
www.reuters.com - January 7 at 2:20 AM
nasdaq.com logoXtant Medical Receives FDA Clearance for the Xsert™ Lumbar Expandable Interbody System
www.nasdaq.com - November 23 at 4:04 PM
reuters.com logoBRIEF-Xtant Medical receives FDA clearance to use allografts in the stand-alone irix-c cervical cage
www.reuters.com - November 15 at 4:07 PM
streetinsider.com logoXtant Medical's (XTNT) Irix-C Cervical Cage Cleared by U.S. FDA
www.streetinsider.com - November 15 at 4:07 PM
globenewswire.com logoXtant Medical Receives FDA Clearance to Use Allografts in the Stand-Alone Irix-C™ Cervical Cage
globenewswire.com - November 15 at 4:07 PM
globenewswire.com logoXtant Medical Announces First Surgical Cases of Xspan™ Laminoplasty Fixation System
globenewswire.com - November 14 at 7:51 AM
seekingalpha.com logoXtant Medical Holdings, Inc. 2016 Q3 - Results - Earnings Call Slides
seekingalpha.com - November 10 at 12:20 PM
globenewswire.com logoXtant Medical Receives Approval of Compliance Plan from NYSE MKT
globenewswire.com - November 1 at 3:56 PM
nasdaq.com logoXtant Medical Announces Commencement of Subscription Period for Previously Announced Rights Offering
www.nasdaq.com - October 31 at 3:55 PM
reuters.com logoBRIEF-Xtant sees Q3 2016 revenue $23 million to $23.3 million
www.reuters.com - October 11 at 3:59 PM
finance.yahoo.com logoXtant™ Medical Pre-Announces Record Third Quarter 2016 Revenue
finance.yahoo.com - October 11 at 3:59 PM
nasdaq.com logoXtant Medical Announces Key Dates Related to Previously Announced Rights Offering
www.nasdaq.com - October 6 at 3:52 PM
biz.yahoo.com logoXTANT MEDICAL HOLDINGS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
biz.yahoo.com - August 10 at 3:22 PM
streetinsider.com logoXtent, Inc. (XTNT) Enters Agreement for Expansion of Pinnacle's InFill Lateral Lumbar Interbody Fusion System
www.streetinsider.com - June 8 at 10:18 PM
nasdaq.com logoPR: Xtant™ Medical to Present at the Source Capital 2016 Disruptive Growth & Healthcare Conference
www.nasdaq.com - February 3 at 12:35 PM
biz.yahoo.com logoXTANT MEDICAL HOLDINGS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule o
biz.yahoo.com - October 15 at 8:13 AM
finance.yahoo.com logoXtant Medical Holdings Announces Uplisting to NYSE MKT
finance.yahoo.com - October 15 at 7:30 AM
biz.yahoo.com logoXTANT MEDICAL HOLDINGS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fin
biz.yahoo.com - October 1 at 4:01 PM


This page was last updated on 9/23/2017 by MarketBeat.com Staff